CS
BBH icon

Credit Suisse’s VanEck Biotech ETF BBH Stock Holding History

Credit Suisse’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-69,717
Closed -$8.85M – 3974
2015
Q4 		$8.85M Sell
69,717
-110,617
-61% -$13.6M 0.01% 1222
2015
Q3 		$20.6M Buy
180,334
+28,230
+19% +$3.74M 0.02% 713
2015
Q2 		$20.5M Sell
152,104
-395,338
-72% -$52.5M 0.02% 821
2015
Q1 		$70.9M Buy
547,442
+443,593
+427% +$55.7M 0.07% 289
2014
Q4 		$12M Sell
103,849
-180,404
-63% -$20.3M 0.01% 1161
2014
Q3 		$30.1M Buy
284,253
+8,671
+3% +$877K 0.02% 736
2014
Q2 		$26.3M Sell
275,582
-53,329
-16% -$4.78M 0.02% 793
2014
Q1 		$29.9M Buy
328,911
+218,422
+198% +$21.2M 0.03% 640
2013
Q4 		$9.78M Buy
110,489
+10,489
+10% +$877K 0.01% 1294
2013
Q3 		$8.27M Buy
100,000
+4,483
+5% +$352K 0.01% 1254
2013
Q2 		$6.54M Buy
+95,517
New +$6.65M 0.01% 1392

Other funds holding BBH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LFM
Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Credit Suisse's BBH Position: Q1 2016 in Review

Credit Suisse sold out of VanEck Biotech ETF (BBH) in Q1 2016, closing a stake of 69,717 shares — an estimated $8.85M sold.

Credit Suisse first reported a position in BBH in Q2 2013 and held it in 11 quarters. The position peaked at $70.9M in Q1 2015. 71 funds tracked by Wall St. Rank hold BBH as of Q1 2016.

  • Credit Suisse reported no remaining VanEck Biotech ETF position as of Q1 2016 after selling out during the quarter.
  • Credit Suisse sold 69,717 VanEck Biotech ETF shares in Q1 2016, an estimated $8.85M.
  • Credit Suisse first reported a position in VanEck Biotech ETF in Q2 2013 and held it in 11 quarters.
  • Credit Suisse's VanEck Biotech ETF position peaked at $70.9M in Q1 2015.
  • 71 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2016.

Based on Credit Suisse's 13F filing for Q1 2016, filed 16 May 2016.